Investigators 2017-11-15T16:58:43+00:00

Investigator Database

Clinilabs Drug Development Corporation works with investigators worldwide to conduct multicenter clinical trials. We identify investigators based on their experience, as well as their ability to recruit patient populations of interest to our sponsors.  Investigators who register in our database become eligible to receive feasibility assessments for  clinical trials under consideration by our sponsor companies. Registration enables you to identify your therapeutic areas of interest, the capabilities of your investigator site staff, and the features of your facility that support the conduct of clinical trials.

Clinilabs drug development Corporation commonly canvases its investigator site database when sponsors request information about study feasibility.   Investigators who are interested in a particular trial may be asked to provide information regarding their experience, capabilities, and ability to enroll subjects. We also may  provide specific information regarding sponsor protocols so that investigators can evaluate the scientific merits of studies, and determine if they are interested in participation. We value the critique of these protocols by investigators, and seek this feedback so that we can provide meaningful commentary back to study sponsors. We view this as an integral part of the scientific process.

Clinilabs drug development Corporation specializes in the development of CNS therapeutics. Therefore, we ask that you identify the specific areas of expertise that you may have.

  • This field is for validation purposes and should be left unchanged.

Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.

– George W. Merck


We empower study participants through informed decisions regarding study participation.

I’m interested in a study


Clinilabs offers a full range of Phase I, II and III clinical development services.

Let’s collaborate